Study of XL114 in Subjects With Non-Hodgkin's Lymphoma

Clinical trial NCT05144347 · TERMINATED

Trial details

NCT number: NCT05144347
Sponsor: Exelixis
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma (NHL)Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)

Start date: 2022-04-12
Primary completion: 2022-11-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.